OrthoPediatrics Corp.
NASDAQ:KIDSMedical - Devices
+$0.19 today
- Market cap
- $826.40M
- Beta
- 1.01
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$1.68
Volume 0.16M
Average 0.16M
KIDS Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
OrthoPediatrics Corp.NASDAQ: KIDS
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue grows in line with its trailing trend
Q1 FY2026 revenue of $59.36M rose 13.3% year over year, behind the +14.5% change in trailing-twelve-month revenue. Sequentially, it fell 3.6% from the prior quarter. Over 3 fiscal years it compounded at +24.6% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 6 analysts of $271.6M (+14.9%) for the fiscal year ending Dec 2026, a pace similar to FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $59.36M-3.6% QoQ
- Last fiscal yearDec 2025
- $236.35M+15.4% YoY
- LTMMar 2026
- $243.3M+14.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +13.3% | +11.7% | -1.6 pp |
| 1 year | +15.4% | +14.9% | -0.5 pp |
| 3-year CAGR | +24.6% | +12.9% | -11.7 pp |
| 5-year CAGR | +12.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 236.35M USD
- Year-over-year change
- +15.4%
- 4-year CAGR
- +24.6%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 236.35M | +15.4% |
| FY2024 | 2024-12-31 | 204.73M | +37.6% |
| FY2023 | 2023-12-31 | 148.73M | +21.6% |
| FY2022 | 2022-12-31 | 122.29M | +24.7% |
| FY2021 | 2021-12-31 | 98.05M | — |
Revenue vs competitors
How KIDS compares with its peers on the latest reported figures
- KIDS's LTM Mar 2026 revenue of $243.3M is the 4th highest of the 8 companies compared; the peer median is $207.32M.
- Its year-over-year change of +14.5% is the 3rd highest of 8, against a peer median of +1.5%.
- Over three fiscal years its annual growth of +24.6% compares with a peer median of +25.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $576.3M | +1.5% | +3.5% | |
| LTM Mar 2026 | $545.76M | +35.4% | +25.8% | |
| LTM Mar 2026 | $301.79M | +9.6% | +26.0% | |
| LTM Mar 2026 | $243.3M | +14.5% | +24.6% | |
| LTM Mar 2026 | $207.32M | -1.7% | +14.5% | |
| LTM Mar 2026 | $127.48M | -19.5% | +40.0% | |
CBLLCeriBell, Inc. | LTM Mar 2026 | $95.07M | +33.7% | +50.9% |
| LTM Mar 2026 | $86.26M | -35.8% | -4.5% | |
| Peer median (excluding KIDS) | $207.32M | +1.5% | +25.8% | |
Competitors are the stored peer set for KIDS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 98.05M | 122.29M | 148.73M | 204.73M | 236.35M |
| Cost of Revenue | 24.65M | 31.63M | 37.48M | 56.13M | 63.69M |
| Gross Profit | 73.4M | 90.66M | 111.25M | 148.6M | 172.66M |
| Gross Margin | 74.9% | 74.1% | 74.8% | 72.6% | 73.1% |
| Research & Development | 5.54M | 8.45M | 10.9M | 11.03M | 9.1M |
| Selling, General & Admin | 85.73M | 104M | 126.12M | 167.09M | 192.56M |
| Operating Expenses | 91.43M | 116.06M | 138M | 178.12M | 201.66M |
| Depreciation & Amortization | 10.68M | 13.1M | 17.39M | 19.08M | 21.25M |
| EBITDA | (7.19M) | (8.69M) | (8.38M) | (20.23M) | (11.94M) |
| EBITDA Margin | -7.3% | -7.1% | -5.6% | -9.9% | -5.1% |
| Operating Income | (18.02M) | (25.4M) | (26.75M) | (29.52M) | (29M) |
| Operating Margin | -18.4% | -20.8% | -18.0% | -14.4% | -12.3% |
| Interest Income | 0 | 0 | 198K | 0 | 0 |
| Interest Expense | 2.25M | 2.42M | 0 | 2.62M | 6M |
| Other Income / Expenses | 636K | 21.71M | 5.44M | (12.41M) | (10.19M) |
| Income Before Tax | (17.39M) | (3.69M) | (21.31M) | (41.93M) | (39.19M) |
| Pre-Tax Margin | -17.7% | -3.0% | -14.3% | -20.5% | -16.6% |
| Income Tax Expense | (1.13M) | (4.95M) | (338K) | (4.11M) | 460K |
| Net Income | (16.26M) | 1.26M | (20.97M) | (37.82M) | (39.65M) |
| Net Margin | -16.6% | 1.0% | -14.1% | -18.5% | -16.8% |
| EPS (Basic) | (0.84) | 0.06 | (0.92) | (1.64) | (1.69) |
| EPS (Diluted) | (0.84) | 0.06 | (0.92) | (1.64) | (1.69) |
| Weighted Avg Shares | 19.27M | 20.7M | 22.68M | 23.08M | 23.46M |
| Weighted Avg Shares (Diluted) | 19.27M | 20.95M | 22.68M | 23.08M | 23.46M |
OrthoPediatrics Corp.
NASDAQ:KIDS
Intrinsic Alpha fair value
Locked
Current Price
$31.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.